FRENCH ANIMAL HEALTH R&D INVESTMENTS

Promoteur – Intermédiaire Financier

VIRBAC SA

Lieu

• France

Description

Investment to support research and development (R&D) for a robust portfolio of next-generation innovative products, addressing global animal health issues, to support Virbac's organic growth and international expansion. The project will be largely coordinated and implemented at the company's French R&D sites.

Objectifs

The project will support the long-term innovation-driven organic growth of the company while enlarging its product portfolio, strengthening its competitive edge and scaling up market share as global player.

Secteur(s)

• Industrie - Industrie manufacturière

Montant BEI envisagé (montant approximatif)

EUR 77 million

Coût total (montant approximatif)

EUR 250 million

Aspects environnementaux

All project activities are expected to be carried out in existing facilities and laboratories without changing their already authorised scope and would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU, as amended. Nevertheless, the Bank's services will review during the project appraisal whether any of the investments requires an EIA, as well as any other environmental details of the project.

Passation des marchés

The promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having the status of a contracting entity, thus not subject to EU rules on public procurement.

Statut

Signé - 25/07/2017